Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schneck

Showing results (1051-1060 of 1,086) with videos related to

Pageof 109
Sort By:
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2024
In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node MatrixNatalie K Livingston, John W Hickey, Hajin Sim, et al.
NPJ Vaccines|February 15, 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent miceIn-Jeong Kim, Michael P Tighe, Paula A Lanthier, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Biomaterials|July 13, 2026
Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineeringMilan Patel, Joseph Choy, Leonardo Cheng, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyT G Murali Dhar, D Nagarathnam, M R Marzabadi, et al.
Nature Communications|July 1, 2025
An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapyYining Zhu, Zhi-Cheng Yao, Shuyi Li, et al.
Cell|October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabNadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite generates a local immunostimulatory niche for cancer immunotherapyYining Zhu, Zhi-Cheng Yao, Shuyi Li, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
Pageof 109

Showing results (1051-1060 of 1,086) with videos related to

Sort By:
Pageof 109
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2024
In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node MatrixNatalie K Livingston, John W Hickey, Hajin Sim, et al.
NPJ Vaccines|February 15, 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent miceIn-Jeong Kim, Michael P Tighe, Paula A Lanthier, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Biomaterials|July 13, 2026
Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineeringMilan Patel, Joseph Choy, Leonardo Cheng, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyT G Murali Dhar, D Nagarathnam, M R Marzabadi, et al.
Nature Communications|July 1, 2025
An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapyYining Zhu, Zhi-Cheng Yao, Shuyi Li, et al.
Cell|October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabNadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite generates a local immunostimulatory niche for cancer immunotherapyYining Zhu, Zhi-Cheng Yao, Shuyi Li, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
Pageof 109